The company’s platform, the NewStem Software Diagnostic Device, provides information to oncologists regarding the presence of mutations in a patient’s tumor profile that may confer resistance to certain anti-cancer drugs, according to a Dec. 14 press release NovelStem International shared with Becker’s.
MSK Innovation Hub will work together with the company to develop new ways to bring better treatments to cancer patients and help build out and commercialize NovelStem’s platform.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
